<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04862052</url>
  </required_header>
  <id_info>
    <org_study_id>OPEN ISR - 001</org_study_id>
    <nct_id>NCT04862052</nct_id>
  </id_info>
  <brief_title>Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis</brief_title>
  <acronym>OPEN-ISR</acronym>
  <official_title>OPtimal trEatment for coroNary Drug Eluting Stent In-Stent Restenosis: Paclitaxel Versus Sirolimus Coated Balloons Versus Everolimus Eluting Stents - The OPEN ISR Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University Heart and Vascular Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Semmelweis University Heart and Vascular Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this open label, randomized study is to compare the safety and efficacy of three&#xD;
      different methods to handle coronary drug eluting stent (DES) in-stent restenosis (ISR).&#xD;
&#xD;
      These are the:&#xD;
&#xD;
        -  Magic Touch - sirolimus coated balloon&#xD;
&#xD;
        -  Emperor - paclitaxel and dextran coated balloon&#xD;
&#xD;
        -  Xience - chromium-cobalt everolimus eluting stent&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 14, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of new onset target vessel myocardial infarction</measure>
    <time_frame>6 months</time_frame>
    <description>New onset myocardial infarction that affects the target vessel treated with either study device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of target vessel revascularization of failure</measure>
    <time_frame>6 months</time_frame>
    <description>The need for further revascularization affecting the target vessel treated with either study device, or the failure of the vessel treated by either study device.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of target lesion revascularization</measure>
    <time_frame>6 months</time_frame>
    <description>The need for further revascularization of the target lesion after treatment with either study device.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage late lumen loss</measure>
    <time_frame>6 months</time_frame>
    <description>Late lumen loss measured via qualitative coronary angiography in treated segment(s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage intraluminal gain after treatment</measure>
    <time_frame>index procedure</time_frame>
    <description>Intraluminal gain after assigned treatment measured via optical coherence tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Square millimetre intraluminal gain after treatment</measure>
    <time_frame>index procedure</time_frame>
    <description>Intraluminal gain after assigned treatment measured via optical coherence tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage intraluminal gain after treatment</measure>
    <time_frame>6 months</time_frame>
    <description>Intraluminal gain after assigned treatment measured via optical coherence tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Square millimeter intraluminal gain after treatment</measure>
    <time_frame>6 months</time_frame>
    <description>Intraluminal gain after assigned treatment measured via optical coherence tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelium coverage in micrometers</measure>
    <time_frame>6 months</time_frame>
    <description>Mean endothelium thickness of stent struts in micrometres measured via optical coherence tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late lumen loss in square millimetres</measure>
    <time_frame>6 months</time_frame>
    <description>Late lumen loss in square millimetres measured via optical coherence tomography</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Coronary Stent Restenosis</condition>
  <arm_group>
    <arm_group_label>Xience chromium-cobalt everolimus eluting stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Xience chromium-cobalt everolimus eluting stent will be evaluated in prior implanted coronary drug eluting stent restenosis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Emperor paclitaxel coated balloon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Emperor paclitaxel coated balloon will be evaluated in prior implanted coronary drug eluting stent restenosis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Magic Touch sirolimus coated balloon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Magic Touch sirolimus coated balloon will be evaluated in prior implanted coronary drug eluting stent restenosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intravascular management of prior implanted coronary drug eluting stent restenosis</intervention_name>
    <description>Intravascular devices will be assessed for the management of prior implanted drug eluting stent restenosis management.</description>
    <arm_group_label>Emperor paclitaxel coated balloon</arm_group_label>
    <arm_group_label>Magic Touch sirolimus coated balloon</arm_group_label>
    <arm_group_label>Xience chromium-cobalt everolimus eluting stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients admitted for intervention of drug eluting stent restenosis&#xD;
&#xD;
          -  Restenosis suitable for all three treatment arms as per 'instructions for use' of the&#xD;
             devices&#xD;
&#xD;
          -  Optional enrollment in the optical coherence tomography sub-study (10-20% of patients)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing coronary angiography after sudden cardiac death&#xD;
&#xD;
          -  Pregnant or nursing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>István F Édes, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Semmelweis University Heart and Vascular Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>István F Édes, MD PhD</last_name>
    <phone>+3614586810</phone>
    <email>edes789@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Szeged, Department of Invasive Cardiology</name>
      <address>
        <city>Szeged</city>
        <state>Csongád-Csanád</state>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zoltán Ruzsa, MD PhD</last_name>
      <phone>+3662545-801</phone>
      <email>zruzsa25@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Semmelweis University Heart and Vascular Center</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>István F Édes, MD PhD</last_name>
      <phone>+3614586810</phone>
      <email>edes789@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 20, 2021</study_first_submitted>
  <study_first_submitted_qc>April 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2021</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Semmelweis University Heart and Vascular Center</investigator_affiliation>
    <investigator_full_name>Istvan Edes</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>drug eluting stent</keyword>
  <keyword>restenosis</keyword>
  <keyword>drug coated balloon</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

